middle.news
Algorae Pharmaceuticals Invites Shareholders to Boost R&D via Loyalty Options Offer
9:21am on Monday 17th of November, 2025 AEDT
•
Healthcare
Read Story
Algorae Pharmaceuticals Invites Shareholders to Boost R&D via Loyalty Options Offer
9:21am on Monday 17th of November, 2025 AEDT
Key Points
Non-renounceable pro-rata Loyalty Options Offer for eligible shareholders
Up to 337.7 million options offered at $0.001 each, exercisable at $0.014 until December 2029
Potential to raise approximately $337,678 initially, with $4.7 million if options fully exercised
Lead Manager Alignment Capital Pty Ltd to receive 30 million options as part of the offer
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE